Idioma:

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review

Fernández-Espartero, María Cruz, MD ; Pérez-Zafrilla, Beatriz, BSc ; Naranjo, Antonio, MD ; Esteban, Carmen, MD ; Ortiz, Ana M., MD, PhD ; Gómez-Reino, Juan J., MD, PhD ; Carmona, Loreto, MD, PhD

Seminars in arthritis and rheumatism, 2011-02, Vol.40 (4), p.330-337 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por

Enviar para

Título:
Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review
Autor: Fernández-Espartero, María Cruz, MD ; Pérez-Zafrilla, Beatriz, BSc ; Naranjo, Antonio, MD ; Esteban, Carmen, MD ; Ortiz, Ana M., MD, PhD ; Gómez-Reino, Juan J., MD, PhD ; Carmona, Loreto, MD, PhD
Assuntos: Adult ; Aged ; Antibodies, Monoclonal - adverse effects ; Antirheumatic Agents - adverse effects ; Biological and medical sciences ; Databases, Factual ; demyelinating disease ; Demyelinating Diseases - etiology ; demyelination ; Diseases of the osteoarticular system ; Diseases of visual field, optic nerve, optic chiasma and optic tracts ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; multiple sclerosis ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Neurology ; Ophthalmology ; optic neuritis ; Rheumatic Diseases - therapy ; Rheumatology ; TNF antagonists ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; Tumor Necrosis Factor-alpha - therapeutic use
É parte de: Seminars in arthritis and rheumatism, 2011-02, Vol.40 (4), p.330-337
Notas: SourceType-Scholarly Journals-1
ObjectType-Feature-4
ObjectType-Undefined-1
content type line 23
ObjectType-Review-2
ObjectType-Article-3
Descrição: Objectives To estimate the rate of demyelinating diseases in patients with rheumatic diseases treated with tumor necrosis factor (TNF) antagonists and to describe the cases reported to 3 different pharmacovigilance sources. Methods All confirmed cases of demyelinating disease, optic neuritis, and multiple sclerosis (MS) in patients with rheumatic diseases treated with TNF-antagonists were reviewed from 3 different sources: (1) the Spanish Registry of biological therapies in rheumatic diseases (BIOBADASER); (2) the Spanish Pharmacovigilance Database of Adverse Drug Reactions (FEDRA); and (3) a systematic review (PubMed, EMBASE, and the Cochrane Library). In BIOBADASER, the incidence rate per 1000 patients was estimated with a 95% confidence interval (95%CI). Results In 21,425 patient-years in BIOBADASER, there were 9 patients with confirmed demyelinating disease, 4 with optic neuritis, and 1 with MS. In addition, 22 patients presented polyneuropathies, paresthesias, dysesthesias, facial palsy, or vocal cord paralysis without confirmed demyelination. The incidence rate of demyelinating disease in patients with rheumatic diseases exposed to TNF antagonists in BIOBADASER was 0.65 per 1000 patient-years (95%CI: 0.39-1.1). The incidence of MS in BIOBADASER was 0.05 (95%CI: 0.01-0.33), while the incidence in the general Spanish population was 0.02 to 0.04 cases per 1000. Compared with BIOBADASER, cases in FEDRA ( n = 19) and in the literature ( n = 48) tend to be younger, have shorter exposure to TNF-antagonists, and recover after discontinuation of the drug. Conclusions It is not clear whether TNF antagonists increase the incidence of demyelinating diseases in patients with rheumatic diseases. Differences between cases depending on the pharmacovigilance source could be explained by selective reporting bias outside registries.
Editor: New York, NY: Elsevier Inc
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review

Fernández-Espartero, María Cruz, MD ; Pérez-Zafrilla, Beatriz, BSc ; Naranjo, Antonio, MD ; Esteban, Carmen, MD ; Ortiz, Ana M., MD, PhD ; Gómez-Reino, Juan J., MD, PhD ; Carmona, Loreto, MD, PhD

New York, NY: Elsevier Inc

Buscando em bases de dados remotas. Favor aguardar.